.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Andrea Forschner, MD

Articles

Exploring Potential Implications of CHOPIN Trial Data in Metastatic Uveal Melanoma

December 16th 2025

Andrea Forschner, MD, and Shaheer Ahmad Khan, DO, discuss the potential clinical implications of the CHOPIN trial in metastatic uveal melanoma.

CHOPIN Trial: Percutaneous Hepatic Perfusion Plus Nivolumab/Ipilimumab in Metastatic Uveal Melanoma

December 16th 2025

Andrea Forschner, MD, and Shaheer Ahmad Khan, DO, break down data from the phase 2 CHOPIN trial evaluating percutaneous hepatic perfusion plus nivolumab and ipilimumab in metastatic uveal melanoma.

Exploring Percutaneous Hepatic Perfusion in Metastatic Uveal Melanoma

December 9th 2025

Andrea Forschner, MD, and Shaheer Ahmad Khan, DO, discuss the use of percutaneous hepatic perfusion in metastatic uveal melanoma.

Current Treatment Standards in Metastatic Uveal Melanoma

December 9th 2025

Andrea Forschner, MD, and Shaheer Ahmad Khan, DO, highlight current treatment approaches in metastatic uveal melanoma.